Jeffrey M Weinberg Selected Research

TNFR-Fc fusion protein (etanercept)

04/2008	Successful treatment with etanercept of von Zumbusch pustular psoriasis in a patient with human immunodeficiency virus.
09/2005	Biologic therapy for psoriasis: an update on the tumor necrosis factor inhibitors infliximab, etanercept, and adalimumab, and the T-cell-targeted therapies efalizumab and alefacept.
01/2005	Advances in therapy for psoriasis: an overview of infliximab, etanercept, efalizumab, alefacept, adalimumab, tazarotene, and pimecrolimus.
10/2004	Treatment of recalcitrant pemphigus vulgaris with the tumor necrosis factor alpha antagonist etanercept.
11/2003	Successful treatment of recalcitrant palmoplantar psoriasis with etanercept.
10/2003	An overview of infliximab, etanercept, efalizumab, and alefacept as biologic therapy for psoriasis.
01/2003	Biologic therapy for psoriasis: the tumor necrosis factor inhibitors infliximab and etanercept.
12/2002	Biologic therapy for psoriasis--the first wave: infliximab, etanercept, efalizumab, and alefacept.

11	Psoriasis (Pustulosis Palmaris et Plantaris) 04/2008 - 12/2002
4	Atopic Dermatitis (Atopic Eczema) 05/2006 - 04/2003
2	Herpes Zoster 01/2008 - 10/2006
2	Pyoderma Gangrenosum 12/2007 - 01/2003
2	Infection 03/2004 - 08/2003
2	Keratosis 05/2003 - 05/2003
1	Herpesviridae Infections (Herpesvirus Infection) 07/2007
1	Postherpetic Neuralgia 10/2006
1	Acne Vulgaris 04/2006
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 09/2005
1	Pemphigus (Pemphigus Vulgaris) 10/2004
1	Rheumatoid Arthritis 07/2003
1	Goiter 07/2003
1	Vesiculobullous Skin Diseases (Subcorneal Pustular Dermatosis) 07/2003
1	Wounds and Injuries (Trauma) 06/2003
1	Vitiligo 05/2003
1	Basal Cell Carcinoma (Rodent Ulcer) 05/2002
1	Bowen's Disease (Disease, Bowen) 01/2002

8	TNFR-Fc fusion protein (etanercept)FDA Link 04/2008 - 12/2002
6	efalizumab FDA Link 05/2006 - 12/2002
5	infliximab (Remicade)FDA Link 09/2005 - 12/2002
5	alefacept (Amevive)FDA Link 09/2005 - 12/2002
4	pimecrolimus (Elidel)FDA Link 01/2005 - 04/2003
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2005 - 01/2003
3	Anti-Bacterial Agents (Antibiotics)IBA 03/2004 - 06/2003
3	imiquimod (Aldara)FDA Link 05/2003 - 01/2002
2	adalimumab (Humira)FDA Link 09/2005 - 01/2005
2	tazarotene (Tazorac)FDA Link 01/2005 - 03/2004
1	OxygenIBA 12/2007
1	famciclovir (Famvir)FDA LinkGeneric 07/2007
1	Herpes Zoster VaccineIBA 10/2006
1	cyclopamineIBA 09/2006
1	Benzoyl Peroxide FDA LinkGeneric 04/2006
1	rituximab (Mabthera)FDA Link 09/2005
1	quinupristin-dalfopristin (Synercid)FDA Link 08/2003
1	linezolid (Zyvox)FDA Link 08/2003
1	AutoantibodiesIBA 07/2003
1	Diclofenac (SR 38)FDA LinkGeneric 05/2003
1	Fluorouracil (Carac)FDA LinkGeneric 05/2003
1	RetinoidsIBA 05/2003
1	Colchicine FDA LinkGeneric 05/2003
1	Tacrolimus (Prograf)FDA Link 05/2003
1	CollagenIBA 01/2003

5	Biological Therapy 09/2005 - 12/2002
1	Mammaplasty (Breast Reconstruction) 01/2008
1	Phototherapy (Light Therapy) 05/2003